Trial Profile
A Randomised, Double-Blind, Double-Dummy, Placebo-Controlled, Crossover Comparison of the Effect of 6-Week Treatment Periods of Tiotropium Inhalation Capsules (18 µg) and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Salmeterol
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Registrational
- Sponsors Boehringer Ingelheim
- 28 Jun 2014 New trial record